Luke Williams
Researcher in psychopharmacology and psychedelic science
Data updated
Papers
Trials
Research Footprint
Luke Williams appears in 9 tracked papers (2015–2026), most studied alongside LSD, Ketamine and Placebo, across Depressive Disorders, Neuroimaging & Brain Measures and Microdosing.
Most-cited paper: The effects of acutely administered 3, 4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level-dependent resting state functional connectivity (182 citations).
Frequent co-authors: Neiloufar Family, Xue Zhang and Laura Michele Hack.
Background & Research
Luke T. J. Williams appears as a coauthor on several human studies of LSD microdosing and related psychopharmacology, including trials in healthy older adults and placebo-controlled work on time perception. Based on the publication record, he seems to work at the intersection of psychedelic science, cognitive neuroscience, and clinical pharmacology.
Key Impact
He is a coauthor on multiple human LSD microdosing and psychedelic neuroimaging studies, contributing to the evidence base on low-dose psychedelic effects on cognition, time perception, and brain function.
Collaboration Network
23 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Luke Williams is associated with.